Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Pharmacodynamic parameters of two different doses of cefepime

Trial Profile

Pharmacodynamic parameters of two different doses of cefepime

Phase of Trial: Phase IV

Latest Information Update: 18 Apr 2008

At a glance

  • Drugs Cefepime (Primary)
  • Indications Bacteraemia; Gram-negative infections; Nosocomial pneumonia
  • Focus Pharmacokinetics
  • Most Recent Events

    • 18 Apr 2008 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top